Trust Point Inc. Celcuity Inc. Transaction History
Trust Point Inc.
- $1.44 Trillion
- Q4 2024
A detailed history of Trust Point Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Trust Point Inc. holds 17,847 shares of CELC stock, worth $230,583. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,847
Previous 18,395
2.98%
Holding current value
$230,583
Previous $274 Million
14.82%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding CELC
# of Institutions
105Shares Held
31.4MCall Options Held
22.1KPut Options Held
3K-
Bvf Inc San Francisco, CA3.47MShares$44.8 Million1.7% of portfolio
-
Baker Bros. Advisors LP New York, NY2.68MShares$34.6 Million0.39% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$33.1 Million2.34% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$30.5 Million1.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$21.3 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $193M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...